Fuan Pharmaceutical (Group) Co Ltd Class A 300194
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.00
- Day Range
- CNY 4.00–4.24
- 52-Week Range
- CNY 2.92–5.15
- Bid/Ask
- CNY 4.18 / CNY 4.19
- Market Cap
- CNY 4.97 Bil
- Volume/Avg
- 68.7 Mil / 30.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 16.94
- Price/Sales
- 1.84
- Dividend Yield (Trailing)
- 1.20%
- Dividend Yield (Forward)
- 1.20%
- Total Yield
- 1.20%
Company Profile
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,292
- Website
- http://www.fapharm.com
Comparables
Valuation
|
Metric
|
300194
|
603367
|
002898
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.94 | 15.47 | — |
Price/Book Value | 1.16 | 1.23 | 3.31 |
Price/Sales | 1.84 | 1.62 | 5.93 |
Price/Cash Flow | 9.25 | 12.15 | 74.81 |
Price/Earnings
300194
603367
002898
Financial Strength
|
Metric
|
300194
|
603367
|
002898
|
|---|---|---|---|
Quick Ratio | 1.18 | 2.84 | 0.58 |
Current Ratio | 1.77 | 3.62 | 1.04 |
Interest Coverage | 10.96 | 84.52 | −1.91 |
Quick Ratio
300194
603367
002898
Profitability
|
Metric
|
300194
|
603367
|
002898
|
|---|---|---|---|
Return on Assets (Normalized) | 0.94% | 6.25% | −0.31% |
Return on Equity (Normalized) | 1.40% | 7.93% | −0.47% |
Return on Invested Capital (Normalized) | 1.12% | 7.24% | 0.41% |
Return on Assets
300194
603367
002898
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Yxcmcynlq | Mpjm | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Wmdydjvbfd | Shmfblz | $69.1 Bil | |
HLN
| Haleon PLC ADR | Rxrqqhr | Vyhn | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Knkwvzfsm | Kdkm | $15.7 Bil | |
VTRS
| Viatris Inc | Dpnkjcb | Qgv | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ckrhbbzg | Fpv | $12.4 Bil | |
CTLT
| Catalent Inc | Tmstvgm | Tsqgs | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Shlllwtk | Jmfjr | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Qxwtysvf | Fdny | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vhrwwdyb | Lvgrzy | $3.5 Bil |